INVO Fertility (IVF) Revenue (2011 - 2026)

INVO Fertility (IVF) has reported Revenue for 16 consecutive years, with $2.0 million the latest figure, recorded in Q1 2026.

• On a quarterly basis, Revenue rose 23.09% year-over-year to $2.0 million in Q1 2026; TTM through Mar 2026 was $7.2 million, a 9.5% increase from a year earlier, with the FY2025 full-year figure at $6.8 million, up 4.73% from the prior year.
• Revenue was $2.0 million for Q1 2026 at INVO Fertility, up from $1.6 million in the prior quarter.
• Over five years, Revenue peaked at $2.0 million in Q1 2026 and troughed at $146135.0 in Q2 2022.
• A 5-year average of $1.1 million and a median of $1.4 million in 2024 frame the typical range for Revenue.
• Across the five-year window, Revenue slumped 90.88% in 2022 and soared 481.38% in 2024, its largest moves.
• Over 5 years, Revenue stood at $278142.0 in 2022, then surged by 396.78% to $1.4 million in 2023, then gained by 22.02% to $1.7 million in 2024, then slipped by 6.09% to $1.6 million in 2025, then gained by 27.28% to $2.0 million in 2026.
• The last three Revenue figures came in at $2.0 million (Q1 2026), $1.6 million (Q4 2025), and $1.8 million (Q3 2025), per Business Quant data.